Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.


Tas F. , Erturk K.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası:
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1177/1078155220909426
  • Dergi Adı: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners